Or choose by keyword:

ABCDEFGHIJKLMNOPQRSTUVWXYZ

A

  • Accreditation
  • Accreditation ISO 15189
  • Acute coronary syndrome
  • Acute diseases
  • Advanced molecular techniques
  • Alcohol related health problems
  • Alzheimer biomarkers
  • Analytical error
  • Analytical interference
  • Antibody development
  • Antioxidant
  • Assay development
  • Assay interference: chemistry assays immunoassays
  • Assessment of patients with bowel symptoms
  • Audit
  • Automation

B

  • Biochemical terrorism
  • Biological variation
  • Biomarkers
  • Blood gas analysis
  • Blood glucose measurement
  • BNP
  • Bone turnover markers

C

  • C-peptide
  • Cancer
  • Cardiac biomarkers
  • Cardiac markers
  • Cardiac troponin assays
  • Cardiology
  • Cardiovascular Risk Assessment
  • Caspase
  • CBRN incident management
  • Cell immunology
  • Chemical weapons
  • Chronic kidney disease
  • Circulating free nucleic acids
  • Circulating microRNAs
  • Circulating Tumor Cells
  • Clinical biochemistry
  • Clinical chemistry
  • Clinical chemistry management
  • Clinical decision limits
  • Clinical mass spectrometry
  • Clinical research
  • Clinical translation
  • Coagulation
  • Colorectal cancer screening
  • Commutability
  • Continuous glucose monitoring (CGM)
  • Coronary artery disease
  • Critical care
  • CSF preanalytical confounders
  • Cystatine C, creatinine, eGFR
  • Cytochrome P450

D

  • Data Mining
  • Diabetes
  • Diagnosis
  • Distance learning
  • DNA Damage
  • DNA methylation assays

E

  • E-learning
  • Education
  • Electrolytes
  • Emerging technologies
  • Endocrinology
  • Enzimology
  • Enzyme measurements
  • EQA HbA1c
  • EQA/PT
  • Evidence based lab. Medicine (EBLM)
  • External quality assessment schemes

F

  • Faecal tests
  • Failure Mode and Effect Analysis (FMEA)
  • Fetal maternal clinical chemistry
  • Flow cytometry

G

  • General clinical biochemistry (Core Lab)
  • Genetics of hereditary diseases
  • Genomics
  • Glucose
  • Glucose POCT
  • Guidelines
  • Guidelines to assess assay performance (CLSI)

H

  • Haematology
  • Harmonization
  • HbA1c
  • Heart failure
  • Hemoglobinopathies and thalassemia
  • HIV
  • HIV immunophenotype
  • Human papillomavirus

I

  • Immunoassay
  • Immunodeficiency
  • Immunology
  • Immunosuppressants
  • Inborn errors in metabolism
  • Inflammation
  • INR POCT
  • Insulin resistence and type 2 diabetes
  • Interference Variants on HbA1c
  • Interpretive commenting
  • ISO 15189
  • ISO 17043

K

  • Knowledge management system

L

  • Lab management
  • Lab quality management
  • Lab-on-a-chip
  • Laboratory accreditation
  • Laboratory analysis
  • Laboratory information system
  • Laboratory report
  • Lean-six sigma
  • Lipid and lipoproteins
  • Lipid management and metabolism
  • Liquid Chromatography
  • Luminescence
  • Lymphoma immunophenotype

M

  • Management
  • Management and quality assurance
  • Mass spectrometry
  • Mass spectrometry - LCMS/MS & GCMS
  • Measurement
  • Medtech Europe code of Ethical Business Practice
  • Metabolic syndrome
  • Method validation/verification protocol
  • Metrology
  • Molecular diagnostics
  • Molecular genetics
  • Molecular tumor biomarkers
  • Myelodisplasia

N

  • Natriuretic peptides
  • Neonatal and metabolic screening
  • Neonatology
  • Neopterin
  • Neurodegenerative biomarkers
  • Neurodegenerative diseases
  • New technologies in communication
  • Newborn screening
  • Nutrition

O

  • Occult blood
  • Oncology
  • Osteoporosis
  • Oxidative stress

P

  • Paediatric health issues
  • Ped. Endocrinology/clinical chemistry
  • Ped. Reference intervals
  • Pediatric clinical chemistry
  • Pediatric endocrine including steroids
  • Pediatrics clinical biochemistry
  • Performance evaluation of measuremet devices
  • Personalized Health care
  • Personalized medicine
  • Pharmacogenetics
  • Pharmacogenomics
  • Pharmacology
  • Pharmacovigliance
  • POCT
  • Poisoning
  • Post analytic quality
  • Preanalytical phase
  • Preanalytical quality assurance
  • Precision medicine
  • Prenatal screening
  • Prenatal screening: double marker
  • Prion
  • Problem-solving techniques
  • Proteomics
  • Public Health

Q

  • Quality assurance
  • Quality control
  • Quality control and quality assurance
  • Quality Indicators
  • Quality management
  • Quality systems
  • Quality Targets HbA1c
  • Quantitative PCR and RT-qPCR

R

  • Red blood cells enzymes
  • Reference intervals
  • Reference Methods
  • Regulatory requirements (FDA)
  • Regulatory requirements for IVDs
  • Renal biomarkers

S

  • Setting up a POCT outside lab.
  • Sexually transmitted infections
  • Standardization
  • Standardization and reference methods (enzyme)
  • Standardization HbA1c
  • Statistical analysis
  • Stem cells
  • Steroid hormon analysis (MS and Immonoassay)
  • Stewardship
  • Sweat chloride testing

T

  • Therapeutic Drug Monitoring
  • Thyroid
  • Thyroid function test standardization
  • Total quality management plan
  • Toxic metal
  • Toxicology
  • Toxicology and Drugs of Abuse testing
  • Trace elements
  • Traceability
  • Troponin
  • Troponin POCT
  • Tubercolosis
  • Tumor markers

U

  • Uncertainty

V

  • Validation
  • Vitamin D
  • Vitamin D assays

W

  • Website & Social Media

Y

  • Young Scientists Education and Training
The International Federation of Clinical Chemistry and Laboratory Medicine.
  • Via Carlo Farini 81
  • 20159 Milano
  • Italy
  • ifcc@ifcc.org
  • eAcademy
  • eJIFCC
  • eNews
  • Executive Board and Council
  • Scientific Division
  • Education and Management
  • Communications and Publications
  • Emerging Technologies
  • Congresses and Conferences
  • Resources and Downloads
  • Service and Contact